A randomized, double-blind, parallel-design, placebo-controlled study to evaluate the effects of 5 mg tadalafil (IC351, LY450190) and 50 mg sildenafil administered once daily for 6 months on visual function in healthy subjects or subjects with mild erectile dysfunction
Latest Information Update: 09 May 2007
At a glance
- Drugs Sildenafil (Primary) ; Tadalafil (Primary)
- Indications Erectile dysfunction
- Focus Pharmacodynamics
- Sponsors Lilly ICOS
- 09 May 2007 New trial record.